Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-19

Clinical Trial Update: Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol

View source ↗

Summary

EU clinical trial protocol completion for Beckman Coulter's Access HIV Ag/Ab Combo Assay evaluating HIV-1 and HIV-2 infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Access HIV Ag/Ab Combo Assay

Snippet

Sponsor: Beckman Coulter, Inc. | Conditions: HIV I Infection, HIV-2 Infection | Status: COMPLETED